What Charted covers, and how.
Charted covers the money and the rules that shape health care: who raised what and from whom, which companies are buying which, what FDA cleared this week, how much Medicare will pay next year, and how the insurers and health-tech companies that depend on those decisions are doing.
We write for the people who make those decisions: founders, investors, health-system and payer executives, and the business-development teams at device and drug companies.
Most of what moves health care is written down somewhere public before it is written up anywhere else. A financing shows up in a Form D. A device decision shows up in FDA's 510(k) database. A payment change shows up in a final rule. We start from those records and from companies' own announcements, and every story lists the documents it was drawn from.
Our trackers count the deals we report, FDA's 510(k) clearances, health-care Form D filings, and new industry-sponsored trials. Each one explains what it counts and links every record to its source.
Charted is not medical advice and does not judge whether a product works. When we describe a device or a drug, we say what the company or regulator says it is for, and we attribute it.
Read how we report, see the masthead, or sign up for Charted Daily.
The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.